bibliographicCitation |
Berger S, Procko E, Margineantu D, Lee EF, Shen BW, Zelter A, Silva D, Chawla K, Herold MJ, Garnier J, Johnson R, MacCoss MJ, Lessene G, Davis TN, Stayton PS, Stoddard BL, Fairlie WD, Hockenbery DM, Baker D. Author response: Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer. 2016 Oct 29;(). doi: 10.7554/elife.20352.031. |